Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
  • Subscribe to newsletter
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
    • CGHE Annual Reports
      • Annual Report 2021
      • Annual Report 2020
  • Programs
    • Programs search
  • Data dashboards
    • Country data dashboards
    • National Hepatitis Elimination Profiles
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • HCV Treatment in Pregnancy
    • Action Plan Systematic Review
    • Hepatitis B Birth Dose Vaccine Systematic Review
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing Systematic Review
    • COVID-19 Evidence Hub
      • COVID-19 and Liver Disease Synthesis
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
    • Hepatitis Elimination Help Desk
  • Resources
    • Search resources
    • Technical Assistance Help Desk and Frequently Asked Questions
  • Webinars
    • Hep Test
    • Linkage to care
    • Strategic Information Collaborative
    • Regional Hepatitis Elimination
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH Research Advancing Hepatitis Elimination
    • Search webinars
  • Elimination champions
    • Elimination Champions
    • Nominations for Elimination Champions
  • News
    • News search
  • Hep C Elimination Tool
    • Access the Tool
    • User Guide
    • Frequently Asked Questions
  1. Home
  2. Resources
  3. Resources search

Resources search

Filter

  • Hepatitis B
  • Hepatitis C
  • Advocacy
  • Data
  • Guidelines
  • Implementation
  • National plans
  • Policy
  • Program evaluation
  • Blood safety
  • Harm reduction
  • HCV testing and linkage to Care
  • HCV treatment
  • Injection safety and infection control
  • Linkage to care
  • Persons who inject drugs: HCV cure as prevention
  • Safer injection practices
  • Screening of pregnant women
  • Strategic data analysis
  • Albania
  • Algeria
  • Andorra
  • Argentina
  • Armenia
  • Australia
  • Austria
  • Azerbaijan
  • Bangladesh
  • Belarus
  • Belgium
  • Bosnia and Herzegovina
  • Brazil
  • Bulgaria
  • Cambodia
  • Cameroon
  • Canada
  • China
  • Congo (Democratic Republic of the)
  • Croatia
  • Cyprus
  • Czech Republic
  • Denmark
  • Egypt
  • England
  • Estonia
  • Ethiopia
  • Fiji
  • Finland
  • France
  • Gambia
  • (-) Georgia
  • Germany
  • Ghana
  • Global
  • Greece
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iraq
  • Ireland
  • Israel
  • Italy
  • Japan
  • Kazakhstan
  • Kiribati
  • Kyrgyzstan
  • Latvia
  • Libya
  • Lithuania
  • Luxembourg
  • Macedonia (the former Yugoslav Republic of)
  • Malaysia
  • Malta
  • Mauritania
  • Mexico
  • Moldova (Republic of)
  • Monaco
  • Mongolia
  • Montenegro
  • Morocco
  • Mozambique
  • Myanmar
  • Netherlands
  • New Zealand
  • Nigeria
  • Norway
  • Pakistan
  • Papua New Guinea
  • Philippines
  • Poland
  • Portugal
  • Romania
  • Russian Federation
  • Rwanda
  • San Marino
  • Saudi Arabia
  • Serbia
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • Spain
  • Sudan
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Tonga
  • Turkey
  • Turkmenistan
  • Uganda
  • Ukraine
  • United Kingdom
  • United States of America
  • Uzbekistan
  • Vanuatu
  • Viet Nam
  • Yemen

Displaying 1 - 12 of 33

  • Data

    Progress of the Elimination of Hepatitis C in Georgia

    15 Dec 2021
    National Center for Disease Control & Public Health, Georgia
    Hepatitis C
  • Policy

    The 2016 Hep-CORE Report: Monitoring the implementation of hepatitis B and C policy recommendations in Europe

    23 Apr 2016
    ELPA
    Hepatitis B
    Hepatitis C
  • Policy

    Webinar- Harnessing the COVID-19 Response Towards Hepatitis C Elimination

    24 Feb 2021
    Treatment Action Group, Médecins du Monde, hepCoalition, and the UNITE network
    Hepatitis C
  • Program evaluation

    Accelerating access to hepatitis C diagnostics and treatment: Overcoming barriers in low- and middle-income countries

    27 Jan 2021
    World Health Organization
    Hepatitis C
  • Advocacy

    Hep Cast- Podcast by World Hepatitis Alliance

    11 Nov 2020
    Apple Podcasts
    Hepatitis B
    Hepatitis C
  • Policy

    Do the most heavily burdened countries have the right policies to eliminate viral hepatitis B and C?

    27 Jul 2020
    Palayew A et al. Lancet Gastro Hep.
    Hepatitis B
    Hepatitis C
  • Program evaluation

    Integration of hepatitis C treatment at harm reduction centers in Georgia-Findings from a patient satisfaction survey

    30 Jul 2020
    Butsashvili M et al. International Journal of Drug Policy
    Hepatitis B
    Hepatitis C
  • National plans

    Action plan for the health sector response to viral hepatitis in the WHO European Region

    03 Apr 2017
    WHO EURO Region
    Hepatitis B
    Hepatitis C
  • National plans

    Georgia Strategic Plan for the Elimination of Hepatitis C 2016-2020

    25 Feb 2016
    Georgia Ministry of Labour, Health and Social Affairs (MoLHSA) and the National Centre for Disease Control and Public Health (NCDC)
    Hepatitis C
  • Program evaluation

    Evaluating the impact of Georgia's hepatitis C elimination plan: lessons learned for the global initiative

    27 Jan 2020
    Lancet Global Health (2020). VOLUME 8, ISSUE 2. https://doi.org/10.1016/S2214-109X(19)30537-6
    Hepatitis C
  • Program evaluation

    Interim effect evaluation of the hepatitis C elimination programme in Georgia: a modelling study

    19 Dec 2019
    Lancet Global Health (2020). VOLUME 8, ISSUE 2, PE244-E253. https://doi.org/10.1016/S2214-109X(19)30483-8
    Hepatitis C
  • Implementation

    Progress and Challenges in a Pioneering Hepatitis C Elimination Program in the Country of Georgia, 2015–2018

    04 Dec 2019
    Averhoff F et al. J Hepatol. 2019 Dec 4. pii: S0168-8278(19)30710-X. doi: 10.1016/j.jhep.2019.11.019. [Epub ahead of print]
    Hepatitis C

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Next page Next ›
  • Last page Last »

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2022 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media